☆ 4.6 Letter

T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients

TRANSPLANTATION (2021)

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Brian J. Boyarsky et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

添加到收藏夹

Article Surgery

Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

David Cucchiari et al.

Summary: The study on 148 kidney transplant recipients showed that the mRNA SARS-CoV-2 vaccine elicited either cellular or humoral response in 65.0% of the patients. Approximately 20.9% of patients were considered to have prior immunization against SARS-CoV-2, while 79.1% were deemed naïve to the virus.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Urology & Nephrology

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

Dominique Bertrand et al.

Summary: Immunization with BNT162b2 appears to be more effective in HDPs, with the immune response in KTRs potentially influenced by immunosuppressive medications. Current vaccinal strategies for KTRs may not provide adequate protection against COVID-19 and may need further improvement.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Review Respiratory System

Advances in the diagnosis of tuberculosis

Christoph Lange et al.

RESPIROLOGY (2010)

添加到收藏夹

T-cell and Antibody Response After 2 Doses of the BNT162b2 Vaccine in a Belgian Cohort of Kidney Transplant Recipients

相关参考文献

Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

Cellular and humoral response after MRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients

Antibody and T Cell Response to SARS-CoV-2 Messenger RNA BNT162b2 Vaccine in Kidney Transplant Recipients and Hemodialysis Patients

Advances in the diagnosis of tuberculosis

导出引文

分享论文